Reinforcing the supply chain of umifenovir and other antiviral drugs with retrosynthetic software.

导出 OA

翻译打印收藏纠错

作者： Yingfu,Lin ^[1] ; Zirong,Zhang ^[1] ; Babak,Mahjour ^[1] ; Di,Wang ^[1] ; Rui,Zhang ^[2] ; Eunjae,Shim ^[2] ; Andrew,McGrath ^[1] ; Yuning,Shen ^[1] ; Nadia,Brugger ^[3] ; Rachel,Turnbull ^[3] ; Sarah,Trice ^[3] ; Shashi,Jasty ^[4] ; Tim,Cernak ^[3]

作者单位： Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA. ^[1] Department of Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA. ^[2] MilliporeSigma, Burlington, MA, 01803, USA. ^[3] Entos, Inc., San Diego, CA, 92037, USA. ^[4] Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA. tcernak@med.umich.edu. ^[5] Department of Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA. tcernak@med.umich.edu. ^[6]

主题词消炎药(Anti-Inflammatory Agents);抗病毒药(Antiviral Agents);药物重新定位(Drug Repositioning);人类(Humans);吲哚类(Indoles);软件(Software)

DOI 10.1038/s41467-021-27547-3

PMID 34916512

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交